---
templateKey: publications-page
title: Publications
subtitle: >-
  TNBC, TGFβ isoforms, Breast cancer Stem Cells, MicroRNA-30, CPSF6,
  Cyclooxygenase-2 
headerImage: /img/dna-1811955_1280.jpg
---
# 2018

* Critical Role for Kinesin 1 Heavy Chain KIF5B in TNBC Aggressive Phenotype Independent of its Partner Protein Kinesin-1 Light Chain KLC1. EMBO J (Submitted).Moamer A, Binothman N, Hachim I, Lebrun JJ, Ali S.
* Prolactin Hormone Exerts Anti-Tumorigenic Effects in HER-2 Overexpressing Breast Cancer Cells through Regulation of Tumor Initiation and Stemness. Nature Scientific Reports (submitted).Hachim I, López-Ozuna VM, Hachim M, Lebrun JJ, Ali S. 
* Blocking microRNA-30 in triple negative breast Cancer can restore pro-apoptotic programs and block tumor development in vivo. Nature Communications (submitted).Fils-Aime N, Poulet S, Neel JC, Dai, M, Hachim, I, Ali S, Lebrun JJ. 
* Dasatinib targeting of breast cancer stem cells sensitize triple negative breast cancer cells to chemotherapy. Clin Cancer Res (submitted).Tian J, Al Raffa F, Dai M, Khandag B, Bakdounes K, Jean-Claude B, Ali S, Lebrun JJ. (2018).
* [Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression.](<Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression.>) Hachim MY, Hachim IY, Dai M, Ali S, Lebrun JJ. Tumour Biol. 2018 Jan;40(1):1010428317748254. doi: 10.1177/1010428317748254
* [KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer.](<KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer.>)
  Tian J, Al-Odaini AA, Wang Y, Korah J, Dai M, Xiao L, Ali S, Lebrun JJ.
  Cell Signal. 2018 Jan;42:1-10. doi: 10.1016/j.cellsig.2017.10.002. Epub 2017 Oct 6.



# 2017

* [Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration.](<Transforming Growth Factor-beta Regulation of Ephrin Type-A Receptor 4 Signaling in Breast Cancer Cellular Migration.>) Hachim IY, Villatoro M, Canaff L, Hachim MY, Boudreault J, Haiub H, Ali S, Lebrun JJ. Sci Rep. 2017 Nov 3;7(1):14976. doi: 10.1038/s41598-017-14549-9.
* [CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer. ](<CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer. >)Binothman N, Hachim IY, Lebrun JJ, Ali S. EBioMedicine. 2017 Jul;21:65-78. doi: 10.1016/j.ebiom.2017.06.023. Epub 2017 Jun 24.
* [Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer.](<Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer.>) Tian J, Hachim MY, Hachim IY, Dai M, Lo C, Al Raffa F, Ali S, Lebrun JJ. doi:10.1038/srep40258 
* [Revealing determinant factors for early breast cancer recurrence by decision tree. ](<Revealing determinant factors for early breast cancer recurrence by decision tree. >)Guo J, Fung BCM, Kuppen PJK, Tollenaar RAEM, Mesker WE, and Lebrun JJ. Information Systems Frontiers (ISF), 13 pages, in press. 

# 2016

Lopez-Ozuna VM, Hachim YI, Hachim YM, Lebrun JJ., Ali, S. 

_**Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy**_. Nature Scientific Reports. 2016 Aug 2; 6:30934. 

doi: 10.1038/srep30934

* Dai M, Zhang C, Ali A, Hong X, Lebrun JJ. 

_**Characterization of CDK4 as a cancer stem cell regulator, prognostic marker and therapeutic target for triple-negative breast cancer**_. Nature Scientific Reports. Oct 19; 6:35383. 

doi:10.1038/srep35383

* Korah J, Canaff L, Lebrun JJ. 

_**The pRb/E2F1 pathway as a novel mediator of TGFβ-induced autophagy**_. J Biol Chem. Jan 29;291(5):2043-54.

doi: 10.1074/jbc.M115.678557. Epub 2015 Nov 23.

* Hachim IY, Shams A, Lebrun JJ, Ali S.

_**A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome**_. Hum Pathol. Jul;53:142-52. 

doi: 10.1016/j.humpath.2016.02.010. Epub 2016 Mar 14

* Hachim IY, Hachim MY, Lopez-Ozuna VM, Ali S, Lebrun JJ. 

_**A dual prognostic role for the TGFβ receptors in human breast cancer**_. Hum Pathol. Jul 18. pii: S0046-8177(16)30143-5. 

doi: 10.1016/j.humpath.2016.07.002
